Gene therapy for prostate cancer (Q74822027)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Gene therapy for prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

13 November 2019

author name string

S B Malkowicz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

13 November 2019

J O Johnson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

13 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

13 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

649-664

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Biological catalysis by RNA.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

A novel gene therapy strategy for elimination of prostate carcinoma cells from human bone marrow

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Site-specific integration by adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Cancer statistics, 1998

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Serum prostate-specific antigen elevation in the post-radical prostatectomy patient

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

NIDDK Workshop on AAV Vectors: Gene Transfer into Quiescent Cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Vaccinia virus: a tool for research and vaccine development

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

The Clinical Usefulness of Prostate Specific Antigen: Update 1994

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Targeting of retroviral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Demonstration of a rational strategy for human prostate cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Prostate-specific antigen expression is regulated by an upstream enhancer

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Role of the retinoblastoma protein in the pathogenesis of human cancer

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Can virus therapy of human cancer be improved by apoptosis induction?

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Proto-oncogenes and tumor suppressor genes in human urological malignancies.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

In vivo cytokine gene transfer by gene gun reduces tumor growth in mice

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Ribozymes in gene therapy.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

One hundred thirteen men with hormone-refractory prostate cancer died today

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Gene gun and other non-viral approaches for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Tumour cell vaccines that secrete interleukin-2 (IL-2) and interferon gamma (IFN gamma) are recognised by T cells while resisting destruction by natural killer (NK) cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70013-7

7 January 2021

10.1016/S0889-8588(05)70013-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684103 AND SRC:MED&resulttype=core&format=json

13 November 2019

1 reference